1. Clinical implications of molecular subtyping in bladder cancer. Issue 4 (July 2019) Authors: Satyal, Uttam; Sikder, Rahmat K.; McConkey, David; Plimack, Elizabeth R.; Abbosh, Philip H. Journal: Current opinion in urology Issue: Volume 29:Issue 4(2019:Jul.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 506 The tumor immune microenvironment of metastatic osteosarcoma is marked by lymphocyte exclusion and impacts patient progression-free survival. (10th December 2020) Authors: Ligon, John; Choi, Woonyoung; Cojocaru, Gady; Fu, Wei; Hsiue, Emily; Oke, Teniola; Morris, Carol; Levin, Adam; Rhee, Daniel; McConkey, David; Anders, Robert; Pardoll, Drew; Llosa, Nicolas Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 506 The tumor immune microenvironment of metastatic osteosarcoma is marked by lymphocyte exclusion and impacts patient progression-free survival. (9th November 2020) Authors: Ligon, John; Choi, Woonyoung; Cojocaru, Gady; Fu, Wei; Hsiue, Emily; Oke, Teniola; Morris, Carol; Levin, Adam; Rhee, Daniel; McConkey, David; Anders, Robert; Pardoll, Drew; Llosa, Nicolas Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A541 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BCG invokes superior STING‐mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer. Issue 2 (10th December 2021) Authors: Lombardo, Kara A; Obradovic, Aleksandar; Singh, Alok Kumar; Liu, James L; Joice, Gregory; Kates, Max; Bishai, William; McConkey, David; Chaux, Alcides; Eich, Marie‐Lisa; Rezaei, M Katayoon; Netto, George J; Drake, Charles G; Tran, Phuoc; Matoso, Andres; Bivalacqua, Trinity J Journal: Journal of pathology Issue: Volume 256:Issue 2(2022) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation. (4th May 2019) Authors: Plote, Devin; Choi, Woonyoung; Mokkapati, Sharada; Sundi, Debasish; Ferguson, James E; Duplisea, Jon; Parker, Nigel R.; Yla-Herttuala, Seppo; Committee, SUO CTC Bladder; McConkey, David; Schluns, Kimberly S.; Dinney, Colin P. Journal: Oncoimmunology Issue: Volume 8:Number 5(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PD53-01 MOLECULAR SUBTYPING OF N-METHYL-N-NITROSOUREA (MNU) RAT MODEL OF UROTHELIAL CARCINOMA REVEALS BOTH LUMINAL AND BASAL SIGNATURES. (May 2022) Authors: Lombardo, Kara; Yoshida, Takahiro; Fitzgerald, Kate; Johnson, Kate; McConkey, David; Singh, Alok; Alam, Ridwan; Kates, Max; Baras, Alex; Bivalacqua, Trinity Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e910 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PD12-03 INTERFERON α GENE THERAPY ALTERS TUMOR METABOLISM IN BLADDER CANCER. (May 2022) Authors: Mokkapati, Sharada; Rudzinski, Jan; Miest, Tanner; Mitra, Anirban; Sood, Akshay; McConkey, David; Dinney, Colin Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MP06-11 MAGNITUDE OF STING SIGNALING DETERMINES ANTITUMOR OUTCOMES, AND CD8+ T CELL MEMORY BY BCG-STING IN UROTHELIAL TUMORS. (May 2022) Authors: Singh, Alok; Praharaj, Monali; Lombardo, Kara; Zhao, Liang; Huang, Joy; Kates, Max; McConkey, David; Bishai, William; Bivalacqua, Trinity Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Urothelial Carcinoma In Situ of the Bladder: Correlation of CK20 Expression With Adaptive Immune Resistance, Response to BCG Therapy, and Clinical Outcome. Issue 2 (February 2021) Authors: Lombardo, Kara A.; Murati Amador, Belkiss; Parimi, Vamsi; Hoffman-Censits, Jean; Choi, Woonyoung; Hahn, Noah M.; Kates, Max; Bivalacqua, Trinity J.; McConkey, David; Hoque, Mohammad O.; Matoso, Andres Journal: Applied immunohistochemistry & molecular morphology Issue: Volume 29:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PD53-11 DIVERGENT THERAPEUTIC OUTCOMES OF STING AGONIST ADU-S100 IN INTRATUMORAL AND INTRAVESICAL TREATMENT REGIMENS IN SYNGENEIC MURINE MB49 AND IN THE N-METHYL-N-NITROSOUREA (MNU) RAT MODEL OF UROTHELIAL CARCINOMA. (May 2022) Authors: Singh, Alok Kumar; Lombardo, Kara; Praharaj, Monali; Liu, James; Becker, Russel; Harris, Kelly; Kates, Max; McConkey, David; Matoso, Andres; Bishai, William R.; Bivalacqua, Trinity Jude Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗